Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags AbbVie Inc Eli Lilly and Co Health & Science
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Pfizer Inc Breaking News: Politics Pharmaceuticals
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Biotech and Pharmaceuticals Health & Science AstraZeneca PLC
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Colgate/Palmolive Co Markets Investing
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Business Abbvie Inc LILLY DRN
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Companies Business US: News
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Amgen Inc Abbvie Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Healthy Returns Roche Holding AG Johnson & Johnson
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Investment Strategy Raytheon Technologies Corp Northrop Grumman Corp
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags AstraZeneca PLC Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Vertex Pharmaceuticals Inc Johnson & Johnson Amgen Inc
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Nike Inc CNBC Sport Papa John's International Inc
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Healthy Returns GE HealthCare Technologies Inc Structure Therapeutics Inc
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Stock Picks Market Outlook Cerence Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Abbvie Inc Merck & Co Inc LILLY DRN
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags PRO: Playbooks GSK plc Meta Platforms Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Investment Strategy Business U/S/ Markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Meta Platforms Inc Brown & Brown Inc Walmart Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags US: News Companies Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Breaking News: Politics Health & Science Novartis AG
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Teva Pharmaceutical Industries Ltd Healthy Returns UnitedHealth Group Inc
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Health care industry Biotechnology Pharmaceuticals
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Business News Breaking News: Technology Technology
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Investment Strategy Business U/S/ Markets
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Breaking news Companies US: News
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Business News Merck & Co Inc Abbvie Inc
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Horizon Therapeutics PLC U/S/ Markets Seagen Inc
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Moderna Inc Business News Abbvie Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags ImmunoGen Inc Investing Markets
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Cerevel Therapeutics Holdings Inc Biotech and Pharmaceuticals Health & Science
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.